Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature.
about
Dystonia and chorea in acquired systemic disordersMovement and Other Neurodegenerative Syndromes in Patients with Systemic Rheumatic Diseases: A Case Series of 8 Patients and Review of the LiteratureNeuropsychiatric lupus: a mosaic of clinical presentationsAutoimmune chorea in adults.Hughes syndrome and epilepsy: when to test for antiphospholipid antibodies?APS and the brain.Primary antiphospholipid antibody syndrome masquerading as progressive supranuclear palsy.Chorea in primary antiphospholipid syndrome is associated with rheumatic fever.Treatment of lupus with corticosteroids.Movement disorders in autoimmune diseases.Chorea and related disorders.Hemichorea with antiphospholipid antibodies in a patient with systemic lupus erythematosus.The neuropathology and pathogenesis of systemic lupus erythematosus.Chorea associated with high titers of antiphospholipid antibodies in the absence of antiphospholipid antibody syndrome.Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies.CNS dysfunction in the antiphospholipid syndrome.Central nervous system lupus: a clinical approach to therapy.Evoked potential studies in the antiphospholipid syndrome: differential diagnosis from multiple sclerosis.Chorea as the first and only manifestation of systemic lupus erythematosusAntiphospholipid-related chorea.Recurrent fetal loss and antiphospholipid antibodies: clinical and therapeutic aspects.Neuroinflammation, neuroautoimmunity, and the co-morbidities of complex regional pain syndrome.Neuropsychiatric involvement in pediatric systemic lupus erythematosus.Movement disorders in paraneoplastic and autoimmune disease.Antiphospholipid syndrome and vascular ischemic (occlusive) diseases: an overview.Revisiting the molecular mechanism of neurological manifestations in antiphospholipid syndrome: beyond vascular damage.Chorea and related movement disorders of paraneoplastic origin: the PNS EuroNetwork experience.Autoimmune basal ganglia disorders.Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome.Mycophenolate mofetil therapy for two cases of antiphospholipid antibody-associated chorea.Antibody binding to neuronal surface in movement disorders associated with lupus and antiphospholipid antibodies.Antiphospholipid antibody syndrome presenting with hemichorea.Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma.Chorea associated with anti-phospholipid antibodies: case report.Atypical movement disorders in antiphospholipid syndrome.Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes.Neurological presentations of the antiphospholipid syndrome: three illustrative cases.
P2860
Q24679812-0E746BED-2D99-448B-9490-20CE0F218132Q26801152-2E3A1012-551B-4CEC-BF5B-9194CC6A971DQ27027588-11242055-91D4-4C33-B3F6-DC23AC9C9DC0Q30540036-1E612947-F7FD-43C3-B172-F405207FF68AQ31101744-1C4314DD-5527-43BE-B990-B999C12F5097Q33196667-0B2A56AE-4938-48F8-8991-83865D94D490Q33346551-D602F4BA-757B-46B6-BC28-2FF824F43EDAQ33396957-8C4C5112-C7A8-4143-9D1A-EA97D32CEBCDQ34226968-F79BA71F-69A9-454E-A011-2C9B64E8A2D2Q34272611-8EF5302E-1EB5-428B-B021-61F0CF4021FDQ34346879-5E35A708-860E-4BAE-BCE6-05BD01394D7DQ34535191-6E189457-A324-42D4-B64F-AEB83FC1BE7AQ34680879-4BDF6CC3-3D9B-47F8-A295-07584860486AQ35108608-3E2BDF70-2F97-413E-A6DC-AC2F275091D9Q35189295-620A9453-1209-4A4A-9E15-D25D602762FDQ35625224-C654C4B8-F58C-48B4-8B72-4A6FCEEDCBE8Q35625240-CDF4E63E-2EEC-4C93-8DF3-0BF18FBE3502Q35636977-F775386B-99FD-4F24-B38A-0091C4E33EC6Q36277546-2349EFC9-A6CF-4BEB-9415-93ACD15D2E06Q36337350-144D86E5-5D2F-4985-8BC4-23A777352A1FQ36625369-901699B6-B4A1-4751-A77E-AB13BD6B9A2DQ36868585-4BC48586-2656-4950-9754-2C5170E71EFFQ36915630-154537B1-1EC0-44BE-9C9E-6A9FADE6FB82Q36993609-C851AF59-9116-4966-9496-60E594408F09Q37045158-0FC2FA8C-6E71-4759-95A7-3E21A2330E3FQ37704593-2C6CBB47-97A1-4CA8-92BA-A2987D33AC01Q37874164-BBC08592-925C-4A5F-95AC-FCD1F2DFD4D7Q38029507-A5FE9F8D-4102-42D8-B19E-CE9E678229F3Q38098473-4D87751C-363B-42FE-BCAF-2CF6B382E9CEQ38927578-1D5E62A6-7A90-43B5-93A7-C556E81861B7Q39541861-0A6B5B81-E83C-4339-B917-0AAF4E1F7821Q42125674-500BC2E4-8E67-46A6-BB5C-18C6E7A6A80BQ42523560-B5F97F08-A55C-4BA7-820D-9EFA6FC43A58Q42786711-29A7464B-641D-42C8-A94A-CC405DBF90AAQ46991264-86A5DC15-8179-4736-80EC-EEA4694CD4DDQ48245672-E0B766DD-3D42-49B9-B283-0F73E7EAF1B6Q53096115-E693D986-D409-4AE9-8D12-B4B95CC3BA98
P2860
Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Chorea in the antiphospholipid ...... ics and the recent literature.
@en
type
label
Chorea in the antiphospholipid ...... ics and the recent literature.
@en
prefLabel
Chorea in the antiphospholipid ...... ics and the recent literature.
@en
P2093
P50
P1433
P1476
Chorea in the antiphospholipid ...... ics and the recent literature.
@en
P2093
P304
P356
10.1097/00005792-199705000-00006
P407
P577
1997-05-01T00:00:00Z